Search by Drug Name or NDC

    NDC 58809-0850-08 Vanacof DMX 18; 396; 10 mg/15mL; mg/15mL; mg/15mL Details

    Vanacof DMX 18; 396; 10 mg/15mL; mg/15mL; mg/15mL

    Vanacof DMX is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 58809-0850
    Product ID 58809-850_b96f9839-a5d0-b356-e053-2995a90aa8cf
    Associated GPIs 43997303100967
    GCN Sequence Number 080577
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 396-18-10 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 47463
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name Vanacof DMX
    Proprietary Name Suffix n/a
    Non-Proprietary Name DEXTROMETHORPHAN HYDROBROMIDE
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 18; 396; 10
    Active Ingredient Units mg/15mL; mg/15mL; mg/15mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name GM Pharmaceuticals, INC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2022-12-31

    Package

    NDC 58809-0850-08 (58809085008)

    NDC Package Code 58809-850-08
    Billing NDC 58809085008
    Package 237 mL in 1 BOTTLE (58809-850-08)
    Marketing Start Date 2019-12-12
    NDC Exclude Flag N
    Pricing Information N/A